P53/p63/p73 in the epidermis in health and disease

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 8, 2014, Pages

  Botchkarev, Vladimir A ^a,b   Flores, Elsa R ^c  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PROTEIN P53; PROTEIN P63; PROTEIN P73; DNA BINDING PROTEIN; NUCLEAR PROTEIN; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ARTICLE; CANCER CHEMOTHERAPY; CARCINOGENESIS; CELL REGENERATION; EPIDERMIS; HAIR FOLLICLE; HUMAN; MORPHOGENESIS; NONHUMAN; PROTEIN FAMILY; PROTEIN FUNCTION; SKIN CANCER; TRANSCRIPTION INITIATION; WOUND HEALING; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN DISEASE; SKIN TUMOR; TUMOR SUPPRESSOR GENE;

DNA-BINDING PROTEINS; EPIDERMIS; GENES, P53; HAIR FOLLICLE; HUMANS; NUCLEAR PROTEINS; SKIN DISEASES; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; WOUND HEALING;

EID: 84923872568     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a015248     Document Type: Article

References (92)

1. Allocati N, Di Ilio C, De Laurenzi V. 2012. p63/p73 in the control of cell cycle and cell death. Exp Cell Res 318: 1285–1290.
2. Antonini D, Russo MT, De Rosa L, Gorrese M, Del Vecchio L, Missero C. 2010. Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. J Invest Dermatol 130: 1249–1257.
3. Belyi VA, Ak P, Markert E, Wang H, Hu W, Puzio-Kuter A, Levine AJ. 2010. The origins and evolution of the p53 family of genes. Cold Spring Harb Perspect Biol 2: a001198.
4. Biernaskie J, Paris M, Morozova O, Fagan BM, Marra M, Pevny L, Miller FD. 2009. SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells. Cell Stem Cell 5: 610–623.
5. Blanpain C, Fuchs E. 2009. Epidermal homeostasis: A balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 10: 207–217.
6. Blanpain C, Mohrin M, Sotiropoulou PA, Passegue E. 2011. DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell 8: 16–29.
7. Bodo E, Tobin DJ, Kamenisch Y, Biro T, Berneburg M, Funk W, Paus R. 2007. Dissecting the impact of chemotherapy on the human hair follicle: A pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy. Am J Pathol 171: 1153–1167.
8. Botchkarev VA, Komarova EA, Siebenhaar F, Botchkareva NV, Komarov PG, Maurer M, Gilchrest BA, Gudkov AV. 2000. p53 is essential for chemotherapy-induced hair loss. Cancer Res 60: 5002–5006.
9. Botchkarev VA, Komarova EA, Siebenhaar F, Botchkareva NV, Sharov AA, Komarov PG, Maurer M, Gudkov AV, Gilchrest BA. 2001. p53 involvement in the control of murine hair follicle regression. Am J Pathol 158: 1913–1919.
10. Botchkarev VA, Gdula MR, Mardaryev AN, Sharov AA, Fessing MY. 2012. Epigenetic regulation of gene expression in keratinocytes. J Invest Dermatol 132: 2505–2521.
11. Botchkareva NV. 2012. MicroRNA/mRNA regulatory networks in the control of skin development and regeneration. Cell Cycle 11: 468–474.
12. Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP, Saville MK, Lane DP. 2005. p53 isoforms can regulate p53 transcriptional activity. Genes Dev 19: 2122–2137.
13. Bruins W, Zwart E, Attardi LD, Iwakuma T, Hoogervorst EM, Beems RB, Miranda B, van Oostrom CT, van den Berg J, van den Aardweg GJ, et al. 2004. Increased sensitivity to UVradiation in mice with a p53 point mutation at Ser389. Mol Cell Biol 24: 8884–8894.
14. Byrne C, Tainsky M, Fuchs E. 1994. Programming gene expression in developing epidermis. Development 120: 2369–2383.
15. Byrne C, Hardman M, Nield K. 2003. Covering the limb—Formation of the integument. J Anat 202: 113–123.
16. Candi E, Schmidt R, Melino G. 2005. The cornified envelope: A model of cell death in the skin. Nat Rev Mol Cell Biol 6: 328–340.
17. Caulin C, Nguyen T, Lang GA, Goepfert TM, Brinkley BR, Cai WW, Lozano G, Roop DR. 2007. An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations. J Clin Invest 117: 1893–1901.
18. Chakravarti D, Su X, Cho MS, Bui NH, Coarfa C, Venkatanarayan A, Benham AL, Flores Gonzalez RE, Alana J, Xiao W, et al. 2014. Induced multipotency in adult keratinocytes through down-regulation of DNp63 or DGCR8. Proc Natl Acad Sci 111: E572–E581.
19. Chikh A, Matin RN, Senatore V, Hufbauer M, Lavery D, Raimondi C, Ostano P, Mello-Grand M, Ghimenti C, Bahta A, et al. 2011. iASPP/p63 autoregulatory feedback loop is required for the homeostasis of stratified epithelia. EMBO J 30: 4261–4273.
20. Chuong CM, Richardson MK. 2009. Pattern formation today. Int J Dev Biol 53: 653–658.
21. Crum CP, McKeon FD. 2010. p63 in epithelial survival, germ cell surveillance, and neoplasia. Annu Rev Pathol 5: 349–371.
22. De Rosa L, Antonini D, Ferone G, Russo MT, Yu PB, Han R, Missero C. 2009. p63 suppresses non-epidermal lineage markers in a bone morphogenetic protein-dependent manner via repression of Smad7. J Biol Chem 284: 30574–30582.
23. Dhouailly D. 2009. A new scenario for the evolutionary origin of hair, feather, and avian scales. J Anat 214: 587–606.
24. Dotto JE, Glusac EJ. 2006. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma. J Cutaneous Pathol 33: 413–417.
25. Driskell I, Oda H, Blanco S, Nascimento E, Humphreys P, Frye M. 2011. The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin. EMBO J 31: 616–629.
26. Ferone G, Thomason HA, Antonini D, De Rosa L, Hu B, Gemei M, Zhou H, Ambrosio R, Rice DP, Acampora D, et al. 2012. Mutant p63 causes defective expansion of ectodermal keratinocytes and impaired FGF signalling in AEC syndrome. EMBO Mol Med 4: 192–205.
27. Fessing MY, Mardaryev AN, Gdula MR, Sharov AA, Sharova TY, Rapisarda V, Gordon KB, Smorodchenko AD, Poterlowicz K, Ferone G, et al. 2011. p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis. J Cell Biol 194: 825–839.
28. Flores ER, Lozano G. 2012. The p53 family grows old. Genes Dev 26: 1997–2000.
29. Flores ER, Sengupta S, Miller JB, Newman JJ, Bronson R, Crowley D, Yang A, McKeon F, Jacks T. 2005. Tumor predisposition in mice mutant for p63 and p73: Evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7: 363–373.
30. Frye M, Benitah SA. 2012. Chromatin regulators in mammalian epidermis. Semin Cell Dev Biol 23: 897–905.
31. Gunschmann C, Stachelscheid H, Akyuz MD, Schmitz A, Missero C, Bruning JC, Niessen CM. 2013. Insulin/IGF-1 controls epidermal morphogenesis via regulation of FoxO-mediated p63 inhibition. Dev Cell 26: 176–187.
32. Guo X, Keyes WM, Papazoglu C, Zuber J, Li W, Lowe SW, Vogel H, Mills AA. 2009. TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol 11: 1451–1457.
33. Hardy MH. 1992. The secret life of the hair follicle. Trends Genet 8: 55–61.
34. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, et al. 2012. A landscape of driver mutations in melanoma. Cell 150: 251–263.
35. Ihrie RA, Marques MR, Nguyen BT, Horner JS, Papazoglu C, Bronson RT, Mills AA, Attardi LD. 2005. Perp is a p63-regulated gene essential for epithelial integrity. Cell 120: 843–856.
36. Ince TA, Cviko AP, Quade BJ, Yang A, McKeon FD, Mutter GL, Crum CP. 2002. p63 coordinates anogenital modeling and epithelial cell differentiation in the developing female urogenital tract. Am J Pathol 161: 1111–1117.
37. Jackson SP, Bartek J. 2009. The DNA-damage response in human biology and disease. Nature 461: 1071–1078.
38. Keyes WM, Pecoraro M, Aranda V, Vernersson-Lindahl E, Li W, Vogel H, Guo X, Garcia EL, Michurina TV, Enikolopov G, et al. 2011. DNp63a is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis. Cell Stem Cell 8: 164–176.
39. Koster MI, Roop DR. 2007. Mechanisms regulating epithelial stratification. Annu Rev Cell Dev Biol 23: 93–113.
40. Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR. 2004. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 18: 126–131.
41. Lane D, Levine A. 2010. p53 research: The past thirty years and the next thirty years. Cold Spring Harb Perspect Biol 2: a000893.
42. Laurikkala J, Mikkola ML, James M, Tummers M, Mills AA, Thesleff I. 2006. p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation. Development 133: 1553–1563.
43. LeBoeuf M, Terrell A, Trivedi S, Sinha S, Epstein JA, Olson EN, Morrisey EE, Millar SE. 2010. Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal keratinocytes. Dev Cell 19: 807–818.
44. Lechler T, Fuchs E. 2005. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 437: 275–280.
45. Lee J, Tumbar T. 2012. Hairy tale of signaling in hair follicle development and cycling. Semin Cell Dev Biol 23: 906–916.
46. Leonard MK, Kommagani R, Payal V, Mayo LD, Shamma HN, Kadakia MP. 2011. DNp63a regulates keratinocyte proliferation by controlling PTEN expression and localization. Cell Death Differ 18: 1924–1933.
47. Li X, Chen J, Yi Y, Li C, Zhang Y. 2012. DNA damage downregulates DNp63a and induces apoptosis independent of wild type p53. Biochem Biophys Res Commun 423: 338–343.
48. Liefer KM, Koster MI, Wang XJ, Yang A, McKeon F, Roop DR. 2000. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res 60: 4016–4020.
49. Lin YL, Sengupta S, Gurdziel K, Bell GW, Jacks T, Flores ER. 2009. p63 and p73 transcriptionally regulate genes involved in DNA repair. PLoS Genet 5: e1000680.
50. Lindner G, Botchkarev VA, Botchkareva NV, Ling G, van der Veen C, Paus R. 1997. Analysis of apoptosis during hair follicle regression (catagen). AmJ Pathol 151: 1601–1617.
51. Maas AM, Bretz AC, Mack E, Stiewe T. 2013. Targeting p73 in cancer. Cancer Lett 332: 229–236.
52. Mardaryev AN, Gdula MR, Yarker JL, Emelianov VN, Poterlowicz K, Sharov AA, Sharova TY, Scarpa JA, Chambon P, Botchkarev VA, et al. 2014. p63 and Brg1 control developmentally regulated higher-order chromatin remodelling at the epidermal differentiation complex locus in epidermal progenitor cells. Development 141: 101–111.
53. McGrath JA, Duijf PH, Doetsch V, Irvine AD, de Waal R, Vanmolkot KR, Wessagowit V, Kelly A, Atherton DJ, Griffiths WA, et al. 2001. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum Mol Genet 10: 221–229.
54. Melino G. 2011. p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cell Death Differ 18: 1487–1499.
55. Mikkola ML. 2007. p63 in skin appendage development. Cell Cycle 6: 285–290.
56. Millar SE. 2002.Molecular mechanisms regulating hair follicle development. J Invest Dermatol 118: 216–225.
57. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. 1999. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708–713.
58. Mulder KW, Wang X, Escriu C, Ito Y, Schwarz RF, Gillis J, Sirokmany G, Donati G, Uribe-Lewis S, Pavlidis P, et al. 2012. Diverse epigenetic strategies interact to control epidermal differentiation. Nature Cell Biol 14: 753–763.
59. Muller PA, Vousden KH. 2013. p53 mutations in cancer. Nat Cell Biol 15: 2–8.
60. Niemann C, Horsley V. 2012. Development and homeostasis of the sebaceous gland. Semin Cell Dev Biol 23: 928–936.
61. Nguyen BC, Lefort K, Mandinova A, Antonini D, Devgan V, Della Gatta G, Koster MI, Zhang Z, Wang J, Tommasi di Vignano A, et al. 2006. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev 20: 1028–1042.
62. Paus R, Haslam IS, Sharov AA, Botchkarev VA. 2013. Pathobiology of chemotherapy-induced hair loss. Lancet Oncol 14: e50–e59.
63. Poulson ND, Lechler T. 2012. Asymmetric cell divisions in the epidermis. Int Rev Cell Mol Biol 295: 199–232.
64. Qian Y, Jung YS, Chen X. 2011.DNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiation. J Biol Chem 286: 12033–12041.
65. Rinne T, Brunner HG, van Bokhoven H. 2007. p63-associated disorders. Cell Cycle 6: 262–268.
66. Rivettidi Val Cervo P, Lena AM, Nicoloso M, Rossi S, Mancini M, Zhou H, Saintigny G, Dellambra E, Odorisio T, Mahe C, et al. 2012. p63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci 109: 1133–1138.
67. Romano RA, Ortt K, Birkaya B, Smalley K, Sinha S. 2009. An active role of the DN isoform of p63 in regulating basal keratin genes K5 and K14 and directing epidermal cell fate. PLoS One 4: e5623.
68. Romano RA, Smalley K, Liu S, Sinha S. 2010. Abnormal hair follicle development and altered cell fate of follicular keratinocytes in transgenic mice expressing DNp63a. Development 137: 1431–1439.
69. Romano RA, Smalley K, Magraw C, Serna VA, Kurita T, Raghavan S, Sinha S. 2012. DNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation. Development 139: 772–782.
70. Rufini A, Niklison-Chirou MV, Inoue S, Tomasini R, Harris IS, Marino A, Federici M, Dinsdale D, Knight RA, Melino G, et al. 2012. TAp73 depletion accelerates aging through metabolic dysregulation. Genes Dev 26: 2009–2014.
71. Schmidt-Ullrich R, Paus R. 2005. Molecular principles of hair follicle induction and morphogenesis. Bioessays 27: 247–261.
72. Sen GL, Boxer LD, Webster DE, Bussat RT, Qu K, Zarnegar BJ, Johnston D, Siprashvili Z, Khavari PA. 2012. ZNF750 is a p63 target gene that induces KLF4 to drive terminal epidermal differentiation. Dev Cell 22: 669–677.
73. Shalom-Feuerstein R, Lena AM, Zhou H, DeLa Forest Divonne S, Van Bokhoven H, Candi E, Melino G, Aberdam D. 2011.DNp63 is an ectodermal gatekeeper of epidermal morphogenesis. Cell Death Differ 18: 887–896.
74. Sharov AA, Siebenhaar F, Sharova TY, Botchkareva NV, Gilchrest BA, Botchkarev VA. 2004. Fas signaling is involved in the control of hair follicle response to chemotherapy. Cancer Res 64: 6266–6270.
75. Simpson CL, Patel DM, Green KJ. 2011. Deconstructing the skin: Cytoarchitectural determinants of epidermal morphogenesis. Nat Rev Mol Cell Biol 12: 565–580.
76. Sotiropoulou PA, Candi A, Mascre G, De Clercq S, Youssef KK, Lapouge G, Dahl E, Semeraro C, Denecker G, Marine JC, et al. 2010. Bcl-2 and acceleratedDNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat Cell Biol 12: 572–582.
77. Sotiropoulou PA, Karambelas AE, Debaugnies M, Candi A, Bouwman P, Moers V, Revenco T, Rocha AS, Sekiguchi K, Jonkers J, et al. 2013. BRCA1 deficiency in skin epidermis leads to selective loss of hair follicle stem cells and their progeny. Genes Dev 27: 39–51.
78. Stenn KS, Paus R. 2001. Controls of hair follicle cycling. Physiol Rev 81: 449–494.
79. Su X, Cho MS, Gi YJ, Ayanga BA, Sherr CJ, Flores ER. 2009a. Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. EMBO J 28: 1904–1915.
80. Su X, Paris M, Gi YJ, Flores ER. 2009b. TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell 5: 64–75.
81. Su X, Chakravarti D, Cho MS, Liu L, Gi YJ, Lin YL, Leung ML, El-Naggar A, Creighton CJ, Suraokar MB, et al. 2010. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature 467: 986–990.
82. Su X, Gi YJ, Chakravarti D, Chan IL, Zhang A, Xia X, Tsai KY, Flores ER. 2012. TAp63 is a master transcriptional regulator of lipid and glucose metabolism. Cell Metab 16: 511–525.
83. Su X, Chakravarti D, Flores ER. 2013. p63 steps into the limelight: Crucial roles in the suppression of tumorigenesis and metastasis. Nat Rev Cancer 13: 136–143.
84. Vanbokhoven H, Melino G, Candi E, Declercq W. 2011. p63, a story of mice and men. J Invest Dermatol 131: 1196–1207.
85. Van Gele M, Kaghad M, Leonard JH, Van Roy N, Naeyaert JM, Geerts ML, Van Belle S, Cocquyt V, Bridge J, Sciot R, et al. 2000.Mutation analysis of P73 and TP53 inMerkel cell carcinoma. Br J Cancer 82: 823–826.
86. Watt FM, Frye M, Benitah SA. 2008. MYC in mammalian epidermis: How can an oncogene stimulate differentiation? Nat Rev Cancer 8: 234–242.
87. Weiss LW, Zelickson AS. 1975. Embryology of the epidermis: Ultrastructural aspects: 1. Formation and early development in the mouse with mammalian comparisons. Acta Derm Venereol 55: 161–168.
88. Westfall MD, Mays DJ, Sniezek JC, Pietenpol JA. 2003. The DNp63 a phosphoprotein binds the p21 and 14-3-3 s promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol 23: 2264–2276.
89. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F. 1998. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305–316.
90. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, et al. 1999. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714–718.
91. Yi R, Poy MN, Stoffel M, Fuchs E. 2008. A skin microRNA promotes differentiation by repressing “stemness.” Nature 452: 225–229.
92. Zhang J, Bardot E, Ezhkova E. 2012. Epigenetic regulation of skin: Focus on the Polycomb complex. Cell Mol Life Sci 69: 2161–2172.